Opinion

Video

Clinical-Decision Making: When to Treat Advanced NSCLC Without Mutational Results

Author(s):

Heather A. Wakelee, MD, FASCO,Jacob Sands, MD

Panelists discuss how to balance the need for comprehensive biomarker testing with the urgency to initiate treatment in patients with advanced disease and explore situations where treatment might be started before test results are available.

  1. Dr Wakelee: Please comment on balancing the need for comprehensive biomarker testing with the urgency to start treatment, especially in patients with advanced disease.
    1. In what types of situations would you initiate treatment prior to having test results?

Related Videos
2 experts are featured in this series.
2 expert is featured in this series.
4 experts are featured in this series.
2 experts are featured in this series.
Related Content